← Back to BLRX

BioLineRx Ltd. - American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2025Filed 14/08/2025Jun 2024Filed 14/08/2025Jun 2023Filed 15/08/2024Jun 2022Filed 30/08/2023Jun 2021Filed 16/08/2022Jun 2020Filed 18/08/2021Jun 2019Filed 06/08/2020Jun 2018Filed 06/08/2019
$0.3$5.4$0
−$3.9$0.5−$19−$7.4−$6.8−$6.8−$5.5−$4.8
$0.00$0.00−$0.02−$0.01−$0.01−$0.03−$0.04−$0.05

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.